Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (81-90 of 246) with videos related to

Pageof 25
Sort By:
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
The Journal of Hand Surgery|February 12, 2008
Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritisBranavan Sivakumar, Mohammed A Akhavani, C Peter Winlove, et al.
Blood|January 19, 2006
Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory responseBetsy J Evans, Alison McDowall, Peter C Taylor, et al.
Viruses|March 27, 2019
The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya ArthritisJ Kennedy Amaral, Peter C Taylor, Mauro Martins Teixeira, et al.
Rheumatology and Therapy|July 10, 2024
Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid ArthritisPeter C Taylor, Bryan Downie, Ling Han, et al.
The Journal of Rheumatology|November 18, 2011
Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumabPeter C Taylor, Christopher Ritchlin, Alan Mendelsohn, et al.
The Journal of Rheumatology|April 17, 2012
Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdomPatricia Guyot, Peter C Taylor, Robin Christensen, et al.
Advances in Therapy|August 7, 2024
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor InhibitorRoberto Caporali, Aditi Kadakia, Oliver Howell, et al.
Arthritis Research & Therapy|December 1, 2012
Raised circulating tenascin-C in rheumatoid arthritisTheresa H Page, Peter J Charles, Anna M Piccinini, et al.
Pageof 25

Showing results (81-90 of 246) with videos related to

Sort By:
Pageof 25
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
The Journal of Hand Surgery|February 12, 2008
Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritisBranavan Sivakumar, Mohammed A Akhavani, C Peter Winlove, et al.
Blood|January 19, 2006
Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory responseBetsy J Evans, Alison McDowall, Peter C Taylor, et al.
Viruses|March 27, 2019
The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya ArthritisJ Kennedy Amaral, Peter C Taylor, Mauro Martins Teixeira, et al.
Rheumatology and Therapy|July 10, 2024
Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid ArthritisPeter C Taylor, Bryan Downie, Ling Han, et al.
The Journal of Rheumatology|November 18, 2011
Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumabPeter C Taylor, Christopher Ritchlin, Alan Mendelsohn, et al.
The Journal of Rheumatology|April 17, 2012
Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdomPatricia Guyot, Peter C Taylor, Robin Christensen, et al.
Advances in Therapy|August 7, 2024
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor InhibitorRoberto Caporali, Aditi Kadakia, Oliver Howell, et al.
Arthritis Research & Therapy|December 1, 2012
Raised circulating tenascin-C in rheumatoid arthritisTheresa H Page, Peter J Charles, Anna M Piccinini, et al.
Pageof 25